You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NIS

Showing 1 - 25 of 1,248
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-low in Metastatic Breast Cancer Patients

Not yet recruiting
  • HER2-negative
    • (no location specified)
    Nov 9, 2023

    A Prospective, Non-interventional, Long-term, Post-Authorisation

    Not yet recruiting
    • Growth Hormone Deficiency
    • No intervention
    • (no location specified)
    Mar 8, 2023

    Solid Tumor, Non Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Rochester (VSV-IFNß-NIS, Pembrolizumab)

    Recruiting
    • Solid Tumor
    • +2 more
    • VSV-IFNβ-NIS
    • Pembrolizumab
    • Rochester, Minnesota
      Mayo Clinic
    Sep 26, 2022

    Risarg® Combined With Endocrine Therapy or Chemotherapy in

    Not yet recruiting
    • HR+HER2- Advanced Breast Cancer
    • Ribociclib
    • Combination chemotherapy
    • (no location specified)
    Nov 20, 2023

    Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

    Recruiting
    • Pancreas Cancer
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Aug 19, 2022

    (NIS) on Sodium-glucose Co-transporter-2 Inhibitors Use in

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Sodium/glucose cotransporter-2 inhibitors (SGLT2i)
    • (no location specified)
    May 22, 2023

    Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Sep 16, 2022

    Immune Surveillance Trial in Klamath Falls (Yeast Fermentate (EpiCor))

    Not yet recruiting
    • Immune Surveillance
    • Yeast Fermentate (EpiCor)
    • Klamath Falls, Oregon
      NIS Labs
    Apr 18, 2023

    Connective Tissue Disease-associated Interstitial Lung Diseases

    Not yet recruiting
    • Lung Diseases, Interstitial
      • (no location specified)
      Apr 6, 2023

      Postoperative Pain Trial in Nis (QLB)

      Recruiting
      • Postoperative Pain
      • QLB
      • Nis, Serbia
        CCNis
      Mar 14, 2023

      Avelumab in Real-World Treatment for Advanced or Metastatic

      Not yet recruiting
      • Bladder Cancer
      • (no location specified)
      Nov 21, 2022

      Learn About the COVID-19 Prescribed Paxlovid in Morocco

      Not yet recruiting
      • COVID-19 Drug Treatment
      • (no location specified)
      Aug 15, 2023

      Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

      Recruiting
      • Myelodysplastic Syndrome
      • +16 more
      • Computed Tomography
      • +6 more
      • Scottsdale, Arizona
      • +2 more
      Feb 3, 2022

      (NIS) on Effectiveness in ND-CKD SHPT Patients

      Not yet recruiting
      • Chronic Kidney Disease
        • (no location specified)
        Jul 12, 2022

        DESTINY Breast Respond HER2-low Europe

        Not yet recruiting
        • Unresectable Breast Cancer
        • +2 more
        • Trastuzumab deruxtecan
        • (no location specified)
        Jul 6, 2023

        Physical Inactivity, Adolescent Obesity, Physical Fitness Trial in Niš (TGfU volleyball intervention, Regular physical education

        Completed
        • Physical Inactivity
        • +5 more
        • TGfU volleyball intervention
        • Regular physical education classes
        • Niš, Serbia
          Primary School "Dušan Radović"
        May 2, 2023

        Immune Surveillance Trial in Klamath Falls (Whole Algae)

        Recruiting
        • Immune Surveillance
        • Whole Algae
        • Klamath Falls, Oregon
          NIS Labs
        Jun 20, 2022

        Urothelial Carcinoma Trial in Miami, New Orleans, Rochester (MV-NIS)

        Recruiting
        • Urothelial Carcinoma
        • MV-NIS
        • Miami, Florida
        • +2 more
        Jun 15, 2021

        Learn More About Iberogast Advance in the Real-world Setting

        Recruiting
        • Functional Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional Dyspepsia
        • +2 more
        • Iberogast (STW5-II, BAY98-7410)
        • Multiple Locations, Many Locations, Germany
          Many Locations
        Jan 16, 2023

        Immune Surveillance Trial in Klamath Falls (Transfer factor from colostrum ultrafiltrate)

        Recruiting
        • Immune Surveillance
        • Transfer factor from colostrum ultrafiltrate
        • Klamath Falls, Oregon
          NIS Labs
        May 11, 2022

        Retrospective NIS to Evaluate the Patient Benefit of TES

        Active, not recruiting
        • Retinitis Pigmentosa
        • Transcorneal Electrostimulation via OkuStim System
        • Heidelberg, Germany
        • +3 more
        May 17, 2022

        Health-related Quality of Life After Switching COPD Patients

        Recruiting
        • Pulmonary Disease, Chronic Obstructive
        • Spiriva® Respimat®
        • +2 more
        • Liestal, Switzerland
          Cantonal Hosp. Baselland,Univ.Med.Dept,Liestal
        Jan 9, 2023

        Relapsing Multiple Sclerosis Trial in Worldwide (fenebrutinib, )

        Recruiting
        • Relapsing Multiple Sclerosis
        • Fullerton, California
        • +16 more
        Jan 24, 2023

        Breast Cancer, Lung Cancer, Hepatocellular Cancer Trial in Worldwide (NIS793, PDR001)

        Completed
        • Breast Cancer
        • +5 more
        • Nashville, Tennessee
        • +11 more
        Jan 28, 2022

        PROVIDENCE - Real-world Study in HER2-positive Unresectable or

        Not yet recruiting
        • Breast Neoplasms
        • +2 more
          • (no location specified)
          Oct 7, 2022